DJ Aerpio Pharmaceuticals Up 25%
By Josh Beckerman
Shares of Aerpio Pharmaceuticals Inc., which is working on drugs for ocular disease and vascular stabilization, were recently up 25% to $2.57.
The company didn't appear to issue any press releases or securities filings Tuesday.
Aerpio said in May that it agreed to merge with Aadi Bioscience Inc.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
August 17, 2021 13:02 ET (17:02 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.